Cloning, stem cells and GMOs: How religious beliefs shape our thinking – Genetic Literacy Project
Genetic Literacy Project |
Cloning, stem cells and GMOs: How religious beliefs shape our thinking
Genetic Literacy Project The concept of “playing God” still bothers certain groups. Christian opinion on GMOs is split. However, when it comes to therapeutic cloning via somatic cell nuclear transfer (SCNT) to create embryonic stem cells, or use of embryos that have been … |
TIME |
How Gene Editing Could Ruin Human Evolution
TIME CRISPR-Cas9, the new gene modification tool, which has been heralded as a means for inserting ourselves into evolution, is itself evolving as a technology, even as you read this. That technology itself can evolve means there is greater urgency for how … Interference: A CRISPR Patent Dispute Roadmap – Bio-IT WorldBio-IT World The Patent Fight Over CRISPR Hinges on a Microscopic DetailPopular Mechanics Next Big Future: CRISPR could make designer babies and help with …Next Big Future Genetic Literacy Project –Post News –Counsel & Heal all 8 news articles » |
|
CardioBreak: Lariat LAA Questions; Synthetic Stem Cells; Alcohol Risk
MedPage Today STAT News took a long look at the Lariat device used off-label for left atrial appendage closure and questioned whether it should have gone through a different regulatory approval process at the FDA. Following the FDA’s approval of a cardiovascular … |
Immuno-Oncology News |
Attacking Glioblastoma by Combining Immune Checkpoint Inhibitors with Gene Therapy Looks Promising
Immuno-Oncology News Attacking an aggressive brain tumor with immunostimulatory gene therapy while enhancing the immune system’s ability to fight it with immune checkpoint inhibitors might be a promising approach to treat patients with glioblastoma multiforme, a brain … |
|
CardioBreak: Lariat LAA Questions; Synthetic Stem Cells; Alcohol Risk
MedPage Today STAT News took a long look at the Lariat device used off-label for left atrial appendage closure and questioned whether it should have gone through a different regulatory approval process at the FDA. Following the FDA’s approval of a cardiovascular … |